Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Matrix stiffening promotes a tumor vasculature phenotype.

Bordeleau F, Mason BN, Lollis EM, Mazzola M, Zanotelli MR, Somasegar S, Califano JP, Montague C, LaValley DJ, Huynh J, Mencia-Trinchant N, Negrón Abril YL, Hassane DC, Bonassar LJ, Butcher JT, Weiss RS, Reinhart-King CA.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):492-497. doi: 10.1073/pnas.1613855114. Epub 2016 Dec 29.

2.

Matrix stiffness regulates vascular integrity through focal adhesion kinase activity.

Wang W, Lollis EM, Bordeleau F, Reinhart-King CA.

FASEB J. 2019 Jan;33(1):1199-1208. doi: 10.1096/fj.201800841R. Epub 2018 Aug 13.

PMID:
30102569
3.

Substrate stiffness regulated migration and angiogenesis potential of A549 cells and HUVECs.

Zhao D, Xue C, Li Q, Liu M, Ma W, Zhou T, Lin Y.

J Cell Physiol. 2018 Apr;233(4):3407-3417. doi: 10.1002/jcp.26189. Epub 2017 Oct 27.

PMID:
28940499
4.

Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X.

PLoS One. 2012;7(12):e52279. doi: 10.1371/journal.pone.0052279. Epub 2012 Dec 31.

5.

Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells.

Haage A, Schneider IC.

FASEB J. 2014 Aug;28(8):3589-99. doi: 10.1096/fj.13-245613. Epub 2014 May 1.

PMID:
24784579
6.

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E.

Mol Cancer Ther. 2005 Nov;4(11):1717-28.

8.

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

Vacca A, Ribatti D, Iurlaro M, Albini A, Minischetti M, Bussolino F, Pellegrino A, Ria R, Rusnati M, Presta M, Vincenti V, Persico MG, Dammacco F.

Int J Clin Lab Res. 1998;28(1):55-68.

PMID:
9594364
9.

Extracellular matrix density regulates the rate of neovessel growth and branching in sprouting angiogenesis.

Edgar LT, Underwood CJ, Guilkey JE, Hoying JB, Weiss JA.

PLoS One. 2014 Jan 22;9(1):e85178. doi: 10.1371/journal.pone.0085178. eCollection 2014.

10.

Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.

Chuang CH, Liu CH, Lu TJ, Hu ML.

Toxicol Appl Pharmacol. 2014 Dec 15;281(3):310-6. doi: 10.1016/j.taap.2014.10.018. Epub 2014 Nov 6.

PMID:
25447407
11.

In situ force mapping of mammary gland transformation.

Lopez JI, Kang I, You WK, McDonald DM, Weaver VM.

Integr Biol (Camb). 2011 Sep;3(9):910-21. doi: 10.1039/c1ib00043h. Epub 2011 Aug 15.

13.

Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.

Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.

Oncol Rep. 2005 Oct;14(4):807-15.

PMID:
16142336
14.

Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling.

Song YH, Shon SH, Shan M, Stroock AD, Fischbach C.

Integr Biol (Camb). 2016 Feb;8(2):205-15. doi: 10.1039/c5ib00277j. Epub 2016 Jan 13.

15.

Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.

Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, Park IC, Rhee CH, Hong SI.

Int J Cancer. 2006 Jun 1;118(11):2711-20.

16.

Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.

Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.

Oncol Rep. 2003 Jan-Feb;10(1):89-95.

PMID:
12469150
17.

CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation.

Gerstel D, Wegwitz F, Jannasch K, Ludewig P, Scheike K, Alves F, Beauchemin N, Deppert W, Wagener C, Horst AK.

Oncogene. 2011 Oct 13;30(41):4275-88. doi: 10.1038/onc.2011.146. Epub 2011 May 2.

PMID:
21532628
18.

Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.

Hajitou A, Sounni NE, Devy L, Grignet-Debrus C, Lewalle JM, Li H, Deroanne CF, Lu H, Colige A, Nusgens BV, Frankenne F, Maron A, Yeh P, Perricaudet M, Chang Y, Soria C, Calberg-Bacq CM, Foidart JM, Noël A.

Cancer Res. 2001 Apr 15;61(8):3450-7.

19.

Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions.

Wang K, Wu F, Seo BR, Fischbach C, Chen W, Hsu L, Gourdon D.

Matrix Biol. 2017 Jul;60-61:86-95. doi: 10.1016/j.matbio.2016.08.001. Epub 2016 Aug 6.

20.

Soft matrices inhibit cell proliferation and inactivate the fibrotic phenotype of deep endometriotic stromal cells in vitro.

Matsuzaki S, Canis M, Pouly JL, Darcha C.

Hum Reprod. 2016 Mar;31(3):541-53. doi: 10.1093/humrep/dev333. Epub 2016 Jan 12.

PMID:
26762314

Supplemental Content

Support Center